Stock Analiz

Guardant Health, Inc. (GH) earnings: date, estimates and history

Price $151.70 · data as of November 13, 2026

Next earnings report

Next reportNot announced yet
Quarterending December 31, 2026
EPS estimate$-0.30
Revenue estimate$370M
Expected EPS growth+39.7%

The date appears here once Guardant Health confirms it, usually two to four weeks before the report.

Track record

Beat EPS estimates3 of 4
Average surprise+6.0%
Average move on report day±14.9%

Guardant Health beat the consensus earnings estimate in 3 of its last 4 reports, by +6.0% on average. On report days the stock moved 14.9% on average, up or down.

Earnings history

ReportedEPS estimateEPS actualSurpriseRevenueRevenue growthStock move
November 5, 2026
Sep/2026
$-0.31$-0.29+6.4%$361M—−10.5%
July 30, 2026
Jun/2026
$-0.39$-0.42−7.8%$335M+44.3%+12.4%
May 7, 2026
Mar/2026
$-0.47$-0.45+5.0%$302M+48.3%+3.7%
October 29, 2025
Sep/2025
$-0.49$-0.39+20.3%$265M+38.5%+32.8%

EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.

Frequently asked questions

When is Guardant Health’s next earnings date?

Guardant Health has not confirmed its next report date yet. Its last report was on November 5, 2026.

Did Guardant Health beat earnings last quarter?

Yes, it reported EPS of $-0.29 on November 5, 2026 against an estimate of $-0.31 (a +6.4% surprise), and the stock moved −10.5% the next trading day.

What EPS do analysts expect next quarter?

The consensus estimate is $-0.30 per share on revenue of about $370M.

Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar